Several receptors for GHRH have been described, both the pituitary-type receptor (pGHRH-R) and four variants generated by alternative splicing (SV1–SV4), which are expressed physiologically in various human tissues, and also in several types of cancer, including breast and prostate cancer [16,17]. Here, GHRH is linked to Familial prostate cancer.